Drug interactions
Brexucabtagene autoleucel + Golimumab
Severity: Major
Brexucabtagene autoleucel and Golimumab: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Golimumab blocks TNF and causes immunosuppression, while brexucabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and B-cell aplasia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
What this interaction means in plain words
Brexucabtagene autoleucel and Golimumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Golimumab belongs to Musculoskeletal.
Why it happens
Additive immunosuppression from TNF blockade and CAR-T related lymphodepletion and B-cell aplasia.
What to do
Avoid starting golimumab around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Golimumab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Golimumab
- Bcg vaccine live + Golimumab Contraindicated
- Etanercept + Golimumab Contraindicated
- Golimumab + Influenza virus vaccine quadrivalent intranasal Contraindicated
- Golimumab + Measles mumps and rubella vaccine Contraindicated
- Golimumab + Measles mumps and rubella vaccine live Contraindicated
- Golimumab + Measles mumps rubella and varicella vaccine live Contraindicated
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Golimumab?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Golimumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Golimumab blocks TNF and causes immunosuppression, while brexucabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and B-cell aplasia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
How serious is the interaction between Brexucabtagene autoleucel and Golimumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting golimumab around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
What other medicines interact with Golimumab?
MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
